Skip to main content
search

Regulatory

Sign up

Latest resources

Featured resource

Upcoming regulatory webinars

Latest regulatory blogs

Meet our experts at the following events

Conference

JSCPT 2025

December 5 - 6, 2025 – Tokyo, Japan
Conference

JPM 2026 44th Annual Healthcare Conference & Biotech Showcase

January 12 - 16, 2026 – San Francisco, CA
Conference

DIA RSIDM 2026

February 2 - 4, 2026 – Bethesda North Marriott Hotel & Conference Center, North Bethesda, MD – Booth 202

All regulatory resources

PHUSE APAC Connect 2026

Certara Products - Pinnacle 21, Clinical Trials, Data Standards, SDTM, Conference

The Next Chapter: What Generative AI Means for Medical Writers [Korean Webinar]

Webinar

Modern SDTM Starts Here: Metadata Management with P21 Enterprise Plus

Certara Products - Pinnacle 21, Data Standards, Webinar

Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema

Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation - PK/PD, Pharmacometrics, Rare and Neglected Diseases, Therapeutic Specialties, Publication

Validation in clinical data management: MacroGenics® Optimizes Validation and Issue Management with Pinnacle 21® Enterprise

Certara Products - Pinnacle 21, Oncology/Hematology, Case Study

Build investor confidence with science-backed strategy

Certara Services, Fact Sheet

Failure to Launch: Building Smarter Strategies to Get the Right Drug to the Right Patient

Certara Services, Drug Development, Webinar

Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation

Cardiovascular, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation - PK/PD, Publication

How To Design a Case Report Form | 7 Best Practice Steps

Certara Products - Pinnacle 21, Data Standards, Blog

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

Certara Services, Clinical Trials, Drug Development, Infectious Disease, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Therapeutic Specialties, Publication

Not Just Another ChatGPT: Why Life Sciences Needs Domain-Specific AI

Discovery - Blog, Blog

Best Practices for AI Prompt Engineering in Life Sciences in 2025

Certara Products, Certara.AI, Blog
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.